Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Régulation des marchés · 07/11/19951 min de lecture
The Upjohn Company and Pharmacia Aktiebolag; Consent Agreement With Analysis to Aid Public Comment
Traduction automatique locale · Langue originale de la source
Résumé
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent agreement, accepted subject to final Commission approval, would require The Upjohn Company and Pharmacia Aktiebolag to divest Pharmacia's assets in ``9-AC,'' a topoisomerase I inhibitor drug for the treatment of colorectal cancer, to a Commission-approved buyer who will ensure that research and development will continue in competition with the merged company's product ``CPT-11,'' a topoisomerase I inhibitor drug developed by Upjohn.
Langue originale de la source: Federal Register — Federal Trade CommissionOuvrir le communiqué original →